In vivo, infusion of reconstitute HDL or purified apoA-I abolishes hypercholesterolemia-induced HSPC expansion and differentiation or MKP proliferation and, thus, suppresses inflammation and atherosclerosis progression [47,50,79]. The gene discussed is APOA1; the disease is familial hypercholesterolemia.